Abstract:Spontaneous mutations in the EEF1A2 gene cause epilepsy and severe neurological disabilities in children. The crystal structure of eEF1A2 protein purified from rabbit skeletal muscle reveals a post-translationally modified dimer that provides information about the sites of interaction with numerous binding partners, including itself, and maps these mutations onto the dimer and tetramer interfaces. The spatial locations of the side chain carboxylates of Glu301 and Glu374, to which phosphatidylethanolamine is un… Show more
“…Are G Proteins with Three Distinct Domains and Very Different Conformations in Their Monomeric and Dimeric Forms eEF1A1 and eEF1A2 fold into three well-characterized structural domains, namely, domain I (residues 4-234), where GDP/GTP binding takes place, and domains II (241-328) and III (337-462/463), both of which are β-barrels. In the monomeric 'GTP conformation' of eEF1A1 [57], Asp110 is involved in a strong ionic interaction with Arg240, but this latter residue is fully exposed to the solvent when two GDP-bound eEF1A2 monomers are mutually associated, as found in the eEF1A2 dimer from rabbit skeletal muscle solved by X-ray crystallography [58,59]. In fact, in this dimeric form, each Arg240 is located in the first half of a proline-rich motif of sequence 235 ILPPTRPTDKPLRLPL 250 that is not fully extended but has been proposed to play a critical role in sequence recognition by the SRC homology 3 (SH3) domain of effectors such as phospholipase Cγ1 (PLCγ1) and adaptors such as Nck1 and Nck2 [59].…”
Section: Eef1a1 and Eef1a2mentioning
confidence: 99%
“…In the monomeric 'GTP conformation' of eEF1A1 [57], Asp110 is involved in a strong ionic interaction with Arg240, but this latter residue is fully exposed to the solvent when two GDP-bound eEF1A2 monomers are mutually associated, as found in the eEF1A2 dimer from rabbit skeletal muscle solved by X-ray crystallography [58,59]. In fact, in this dimeric form, each Arg240 is located in the first half of a proline-rich motif of sequence 235 ILPPTRPTDKPLRLPL 250 that is not fully extended but has been proposed to play a critical role in sequence recognition by the SRC homology 3 (SH3) domain of effectors such as phospholipase Cγ1 (PLCγ1) and adaptors such as Nck1 and Nck2 [59].…”
Section: Eef1a1 and Eef1a2mentioning
confidence: 99%
“…Careful examination of the monomer-monomer interface [59] revealed the presence and high relevance for dimer stabilization of Gly70, Ile71, Asp252 and Arg423 and also Tyr86 and Lys100, which are spatially close to Asp91 and Phe98. This profusion of amino acids that are not only strictly conserved throughout evolution [34], but also substituted due to missense mutations in children affected with severe neurodevelopmental disorders (Table 2), appears to support a role for the eEF1A2 dimer (Figure 2) in cellular functions that are necessarily distinct from that of delivering tRNA to the ribosome.…”
Section: Eef1a1 and Eef1a2mentioning
confidence: 99%
“…Furthermore, the higher-order association of two eEF1A2 dimers in the crystal lattice gives rise to a tetramer in which the negatively charged carboxylates of Glu122 and Glu124 (also found in Table 2) interact (at the dimer-dimer interface) with the positively charged side chains of Arg166 and Lys154. In addition, Glu122 and Glu124 flank Phe123, a hydrophobic residue located at the tip of a loop that has been posited [59] as key for the interaction of the membranebound eEF1A2 dimer with PI4KB, a crucial enzyme (EC 2.7.1.67) in the biosynthesis of phosphoinositides that play essential roles in signal transduction, cytokinesis, regulation of lipid and protein transport from the Golgi complex to the PM and determination and maintenance of the identity of several cell organelles [40,60]. 2 because of their known involvement in genetic disorders are colored in green and labeled in one-character notation.…”
Section: Eef1a1 and Eef1a2mentioning
confidence: 99%
“…A physiological pH increase promotes the GTP-dependent binding of eEF1A to aa-tRNAs, thus changing its spatial distribution and upregulating protein translation [94]. This dynamic functional switch is likely to be driven by a conformational transition brought about by what can be considered [95] a PTM by protons, i.e., an alteration in the charge of crucial amino acid side chains (e.g., Asp35, Glu45, Glu68, Asp91, His95, Asp252, Asp362 and His367 [59]). Likewise, other PTMs can be seen as a source of additional functional richness and diversity in eEF1A1 and eEF1A2 [49] that enable these ubiquitous proteins to interact with other molecular partners in other cellular processes different from translation.…”
Section: Post-translational Modifications In Eef1a1/2mentioning
eEF1A1 and eEF1A2 are paralogous proteins whose presence in most normal eukaryotic cells is mutually exclusive and developmentally regulated. Often described in the scientific literature under the collective name eEF1A, which stands for eukaryotic elongation factor 1A, their best known activity (in a monomeric, GTP-bound conformation) is to bind aminoacyl-tRNAs and deliver them to the A-site of the 80S ribosome. However, both eEF1A1 and eEF1A2 are endowed with multitasking abilities (sometimes performed by homo- and heterodimers) and can be located in different subcellular compartments, from the plasma membrane to the nucleus. Given the high sequence identity of these two sister proteins and the large number of post-translational modifications they can undergo, we are often confronted with the dilemma of discerning which is the particular proteoform that is actually responsible for the ascribed biochemical or cellular effects. We argue in this review that acquiring this knowledge is essential to help clarify, in molecular and structural terms, the mechanistic involvement of these two ancestral and abundant G proteins in a variety of fundamental cellular processes other than translation elongation. Of particular importance for this special issue is the fact that several de novo heterozygous missense mutations in the human EEF1A2 gene are associated with a subset of rare but severe neurological syndromes and cardiomyopathies.
“…Are G Proteins with Three Distinct Domains and Very Different Conformations in Their Monomeric and Dimeric Forms eEF1A1 and eEF1A2 fold into three well-characterized structural domains, namely, domain I (residues 4-234), where GDP/GTP binding takes place, and domains II (241-328) and III (337-462/463), both of which are β-barrels. In the monomeric 'GTP conformation' of eEF1A1 [57], Asp110 is involved in a strong ionic interaction with Arg240, but this latter residue is fully exposed to the solvent when two GDP-bound eEF1A2 monomers are mutually associated, as found in the eEF1A2 dimer from rabbit skeletal muscle solved by X-ray crystallography [58,59]. In fact, in this dimeric form, each Arg240 is located in the first half of a proline-rich motif of sequence 235 ILPPTRPTDKPLRLPL 250 that is not fully extended but has been proposed to play a critical role in sequence recognition by the SRC homology 3 (SH3) domain of effectors such as phospholipase Cγ1 (PLCγ1) and adaptors such as Nck1 and Nck2 [59].…”
Section: Eef1a1 and Eef1a2mentioning
confidence: 99%
“…In the monomeric 'GTP conformation' of eEF1A1 [57], Asp110 is involved in a strong ionic interaction with Arg240, but this latter residue is fully exposed to the solvent when two GDP-bound eEF1A2 monomers are mutually associated, as found in the eEF1A2 dimer from rabbit skeletal muscle solved by X-ray crystallography [58,59]. In fact, in this dimeric form, each Arg240 is located in the first half of a proline-rich motif of sequence 235 ILPPTRPTDKPLRLPL 250 that is not fully extended but has been proposed to play a critical role in sequence recognition by the SRC homology 3 (SH3) domain of effectors such as phospholipase Cγ1 (PLCγ1) and adaptors such as Nck1 and Nck2 [59].…”
Section: Eef1a1 and Eef1a2mentioning
confidence: 99%
“…Careful examination of the monomer-monomer interface [59] revealed the presence and high relevance for dimer stabilization of Gly70, Ile71, Asp252 and Arg423 and also Tyr86 and Lys100, which are spatially close to Asp91 and Phe98. This profusion of amino acids that are not only strictly conserved throughout evolution [34], but also substituted due to missense mutations in children affected with severe neurodevelopmental disorders (Table 2), appears to support a role for the eEF1A2 dimer (Figure 2) in cellular functions that are necessarily distinct from that of delivering tRNA to the ribosome.…”
Section: Eef1a1 and Eef1a2mentioning
confidence: 99%
“…Furthermore, the higher-order association of two eEF1A2 dimers in the crystal lattice gives rise to a tetramer in which the negatively charged carboxylates of Glu122 and Glu124 (also found in Table 2) interact (at the dimer-dimer interface) with the positively charged side chains of Arg166 and Lys154. In addition, Glu122 and Glu124 flank Phe123, a hydrophobic residue located at the tip of a loop that has been posited [59] as key for the interaction of the membranebound eEF1A2 dimer with PI4KB, a crucial enzyme (EC 2.7.1.67) in the biosynthesis of phosphoinositides that play essential roles in signal transduction, cytokinesis, regulation of lipid and protein transport from the Golgi complex to the PM and determination and maintenance of the identity of several cell organelles [40,60]. 2 because of their known involvement in genetic disorders are colored in green and labeled in one-character notation.…”
Section: Eef1a1 and Eef1a2mentioning
confidence: 99%
“…A physiological pH increase promotes the GTP-dependent binding of eEF1A to aa-tRNAs, thus changing its spatial distribution and upregulating protein translation [94]. This dynamic functional switch is likely to be driven by a conformational transition brought about by what can be considered [95] a PTM by protons, i.e., an alteration in the charge of crucial amino acid side chains (e.g., Asp35, Glu45, Glu68, Asp91, His95, Asp252, Asp362 and His367 [59]). Likewise, other PTMs can be seen as a source of additional functional richness and diversity in eEF1A1 and eEF1A2 [49] that enable these ubiquitous proteins to interact with other molecular partners in other cellular processes different from translation.…”
Section: Post-translational Modifications In Eef1a1/2mentioning
eEF1A1 and eEF1A2 are paralogous proteins whose presence in most normal eukaryotic cells is mutually exclusive and developmentally regulated. Often described in the scientific literature under the collective name eEF1A, which stands for eukaryotic elongation factor 1A, their best known activity (in a monomeric, GTP-bound conformation) is to bind aminoacyl-tRNAs and deliver them to the A-site of the 80S ribosome. However, both eEF1A1 and eEF1A2 are endowed with multitasking abilities (sometimes performed by homo- and heterodimers) and can be located in different subcellular compartments, from the plasma membrane to the nucleus. Given the high sequence identity of these two sister proteins and the large number of post-translational modifications they can undergo, we are often confronted with the dilemma of discerning which is the particular proteoform that is actually responsible for the ascribed biochemical or cellular effects. We argue in this review that acquiring this knowledge is essential to help clarify, in molecular and structural terms, the mechanistic involvement of these two ancestral and abundant G proteins in a variety of fundamental cellular processes other than translation elongation. Of particular importance for this special issue is the fact that several de novo heterozygous missense mutations in the human EEF1A2 gene are associated with a subset of rare but severe neurological syndromes and cardiomyopathies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.